SMS Investments

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 28, 2016	Promethera Biosciences	$10.9M Series C Extension	—	Boehringer Ingelheim, Cell Innovation Partners, Fund+, LifeLiver, Muneki Handa, SRIW, Vesalius Biocapital
Nov 25, 2014	Promethera Biosciences	$25.4M Series C	Boehringer Ingelheim, Vesalius Biocapital	Mitsui & Co. Global Investment, Pall-ATMI LifeSciences, SFPI-FPIM, Shire, SRIW, VIVES Louvain Technology Fund

Total Raised

N/A

Valuation

N/A